Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study - PubMed (original) (raw)
Controlled Clinical Trial
. 2011 Sep;53(3 Suppl 1):43-9.
G Belcaro, U Cornelli, R Luzzi, S Togni, M Dugall, M R Cesarone, B Feragalli, E Ippolito, B M Errichi, L Pellegrini, A Ledda, A Ricci, P Bavera, M Hosoi, S Stuard, M Corsi, S Errichi, G Gizzi
Affiliations
- PMID: 22108476
Controlled Clinical Trial
Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study
G Appendino et al. Panminerva Med. 2011 Sep.
Abstract
Aim: The aim of the present study was to evaluate the improvement of diabetic microangiopathy in patients suffering from this condition since at least five years, and whose disease was managed without insulin.
Methods: Curcumin, the orange pigment of turmeric, has recently received increasing attention because of its antioxidant properties, mediated by both direct oxygen radical quenching and by induction of anti-oxidant responses via Nrf2 activation. This aspect, combined with the beneficial effects on endothelial function and on tissue and plasma inflammatory status, makes curcumin potentially useful for the management of diabetic microangiopathy. To further evaluate this, Meriva, a lecithinized formulation of curcumin, was administered at the dosage of two tablets/day (1 g Meriva/day) to 25 diabetic patients for four weeks. A comparable group of subjects followed the best possible management for this type of patients.
Results: All subjects in the treatment and control group completed the follow-up period; there were no dropouts. In the treatment group, at four weeks, microcirculatory and clinical evaluations indicated a decrease in skin flux (P<0.05) at the surface of the foot, a finding diagnostic of an improvement in microangiopathy, the flux being generally increased in patients affected by diabetic microangiopathy. Also, a significant decrease in the edema score (P<0.05) and a corresponding improvement in the venoarteriolar response (P<0.05) were observed. The PO2 increased at four weeks (P<0.05), as expected from a better oxygen diffusion into the skin due to the decreased edema. These findings were present in all subjects using Meriva, while no clinical or microcirculatory effects were observed in the control group.
Conclusion: Meriva was, in general, well tolerated, and these preliminary findings suggest the usefulness of this curcumin formulation for the management of diabetic microangiopathy, opening a window of opportunities to be evaluated in more prolonged and larger studies. The molecular mechanisms involved in the beneficial effects of curcumin on microcirculation and edema are also worth investigation.
Similar articles
- Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy.
Steigerwalt R, Nebbioso M, Appendino G, Belcaro G, Ciammaichella G, Cornelli U, Luzzi R, Togni S, Dugall M, Cesarone MR, Ippolito E, Errichi BM, Ledda A, Hosoi M, Corsi M. Steigerwalt R, et al. Panminerva Med. 2012 Dec;54(1 Suppl 4):11-6. Panminerva Med. 2012. PMID: 23241930 Clinical Trial. - Treatment of diabetic microangiopathy and edema with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled randomized study.
Incandela L, Belcaro G, Cesarone MR, De Sanctis MT, Nargi E, Patricelli P, Bucci M. Incandela L, et al. Angiology. 2001 Oct;52 Suppl 2:S27-31. Angiology. 2001. PMID: 11666119 Clinical Trial. - Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study.
Ledda A, Belcaro G, Dugall M, Luzzi R, Scoccianti M, Togni S, Appendino G, Ciammaichella G. Ledda A, et al. Panminerva Med. 2012 Dec;54(1 Suppl 4):17-22. Panminerva Med. 2012. PMID: 23241931 Clinical Trial. - The emerging role of curcumin for improving vascular dysfunction: A review.
Campbell MS, Fleenor BS. Campbell MS, et al. Crit Rev Food Sci Nutr. 2018;58(16):2790-2799. doi: 10.1080/10408398.2017.1341865. Epub 2017 Aug 21. Crit Rev Food Sci Nutr. 2018. PMID: 28662351 Review. - Exercise and diabetic microangiopathy.
McMillan DE. McMillan DE. Diabetes. 1979 Jan;28 Suppl 1:103-6. doi: 10.2337/diab.28.1.s103. Diabetes. 1979. PMID: 367850 Review. No abstract available.
Cited by
- Curcumin C3 complex®/Bioperine® has antineoplastic activity in mesothelioma: an in vitro and in vivo analysis.
Di Meo F, Filosa S, Madonna M, Giello G, Di Pardo A, Maglione V, Baldi A, Crispi S. Di Meo F, et al. J Exp Clin Cancer Res. 2019 Aug 16;38(1):360. doi: 10.1186/s13046-019-1368-8. J Exp Clin Cancer Res. 2019. PMID: 31419989 Free PMC article. - The environmental pollutant, polychlorinated biphenyls, and cardiovascular disease: a potential target for antioxidant nanotherapeutics.
Gupta P, Thompson BL, Wahlang B, Jordan CT, Zach Hilt J, Hennig B, Dziubla T. Gupta P, et al. Drug Deliv Transl Res. 2018 Jun;8(3):740-759. doi: 10.1007/s13346-017-0429-9. Drug Deliv Transl Res. 2018. PMID: 28975503 Free PMC article. Review. - Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.
Aggarwal BB, Gupta SC, Sung B. Aggarwal BB, et al. Br J Pharmacol. 2013 Aug;169(8):1672-92. doi: 10.1111/bph.12131. Br J Pharmacol. 2013. PMID: 23425071 Free PMC article. Review. - Chondroprotective effect of curcumin and lecithin complex in human chondrocytes stimulated by IL-1β via an anti-inflammatory mechanism.
Kim L, Kim JY. Kim L, et al. Food Sci Biotechnol. 2018 Sep 18;28(2):547-553. doi: 10.1007/s10068-018-0470-6. eCollection 2019 Apr. Food Sci Biotechnol. 2018. PMID: 30956867 Free PMC article.